Bionoid Pharma Correlations
| BINP Stock | USD 0.11 0.09 45.00% |
The correlation of Bionoid Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Bionoid Pharma Correlation With Market
Good diversification
The correlation between Bionoid Pharma and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and DJI in the same portfolio, assuming nothing else is changed.
Bionoid |
The ability to find closely correlated positions to Bionoid Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bionoid Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bionoid Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bionoid Pharma to buy it.
Moving together with Bionoid Pink Sheet
| 0.69 | TEVA | Teva Pharma Industries | PairCorr |
| 0.62 | LNDNF | Lundin Energy AB | PairCorr |
| 0.61 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
Moving against Bionoid Pink Sheet
| 0.58 | WMT | Walmart Aggressive Push | PairCorr |
| 0.38 | GMNFF | GobiMin | PairCorr |
| 0.57 | T | ATT Inc Sell-off Trend | PairCorr |
| 0.55 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.52 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.44 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.44 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
| 0.35 | MSFT | Microsoft Aggressive Push | PairCorr |
| 0.32 | HD | Home Depot | PairCorr |
Related Correlations Analysis
| -0.19 | 0.0 | 0.73 | 0.36 | 0.7 | 0.0 | SDHC | ||
| -0.19 | 0.0 | -0.52 | -0.11 | 0.09 | 0.0 | UHG | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | MAHN | ||
| 0.73 | -0.52 | 0.0 | 0.23 | 0.57 | 0.0 | JBGS | ||
| 0.36 | -0.11 | 0.0 | 0.23 | -0.1 | 0.0 | TSRYF | ||
| 0.7 | 0.09 | 0.0 | 0.57 | -0.1 | 0.0 | MHO | ||
| 0.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | DWWEF | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Bionoid Pink Sheet performing well and Bionoid Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bionoid Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SDHC | 2.40 | (0.22) | 0.00 | (0.12) | 0.00 | 6.08 | 13.47 | |||
| UHG | 2.99 | (0.25) | 0.00 | (0.02) | 0.00 | 7.79 | 17.32 | |||
| MAHN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| JBGS | 1.14 | (0.17) | 0.00 | (0.06) | 0.00 | 2.58 | 9.14 | |||
| TSRYF | 1.00 | (0.21) | 0.00 | 1.07 | 0.00 | 1.71 | 18.03 | |||
| MHO | 1.67 | (0.07) | (0.02) | 0.06 | 2.39 | 3.69 | 10.66 | |||
| DWWEF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bionoid Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |